Interpretation of updated NCCN guidelines for small cell lung cancer (version 1. 2022) / 中国胸心血管外科临床杂志
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
; (12): 1272-1276, 2021.
Article
de Zh
| WPRIM
| ID: wpr-904707
Bibliothèque responsable:
WPRO
ABSTRACT
@#The National Comprehensive Cancer Network (NCCN) released the latest version 1, 2022 of "NCCN guidelines for the clinical diagnosis and treatment of small cell lung cancer" (hereinafter referred to as "guideline"). Based on high-quality evidence-based medicine, this guideline provides references of clinical diagnosis and treatment for clinicians around the world. Compared with the version 3, 2021 of the "guideline", updates and revisions mainly focused on the progress of radiotherapy and systemic treatment. This article will interpret the updated therapy content in this new version of the "guideline".
Texte intégral:
1
Base de données:
WPRIM
Type d'étude:
Guideline
Langue:
Zh
Journal:
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
Année:
2021
Type de document:
Article